RS52818B - Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat - Google Patents
Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginatInfo
- Publication number
- RS52818B RS52818B YU20050276A YUP27605A RS52818B RS 52818 B RS52818 B RS 52818B YU 20050276 A YU20050276 A YU 20050276A YU P27605 A YUP27605 A YU P27605A RS 52818 B RS52818 B RS 52818B
- Authority
- RS
- Serbia
- Prior art keywords
- alginate
- sodium
- controlled release
- release pharmaceutical
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200200242A SI21300A (sl) | 2002-10-08 | 2002-10-08 | Farmacevtske formulacije z alginati |
PCT/SI2003/000034 WO2004032904A1 (fr) | 2002-10-08 | 2003-10-06 | Compositions pharmaceutiques contenant des alginates |
Publications (2)
Publication Number | Publication Date |
---|---|
RS20050276A RS20050276A (en) | 2007-06-04 |
RS52818B true RS52818B (sr) | 2013-10-31 |
Family
ID=32091983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU20050276A RS52818B (sr) | 2002-10-08 | 2003-10-06 | Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1560568B1 (fr) |
AU (1) | AU2003273212A1 (fr) |
EA (1) | EA007488B1 (fr) |
HR (1) | HRP20050312B1 (fr) |
PL (1) | PL208591B1 (fr) |
RS (1) | RS52818B (fr) |
SI (2) | SI21300A (fr) |
UA (1) | UA80990C2 (fr) |
WO (1) | WO2004032904A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5367266B2 (ja) | 2004-10-12 | 2013-12-11 | エフエムシー バイオポリマー エイエス | 自己ゲル化性アルギネート系及びその使用 |
WO2009032158A2 (fr) | 2007-08-28 | 2009-03-12 | Fmc Corporation, Inc. | Systèmes d'alginate à auto-gélification retardée et leurs utilisations |
CN108853039B (zh) * | 2018-08-07 | 2021-03-09 | 河北君临药业有限公司 | 一种克拉霉素分散片及其生产工艺 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE66143T1 (de) * | 1985-01-11 | 1991-08-15 | Abbott Lab | Feste zubereitung mit langsamer freisetzung. |
EP0275336A1 (fr) * | 1987-01-20 | 1988-07-27 | Knoll Ag | Composition pharmaceutique à effet retard |
US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
SI20108B (en) * | 1997-06-11 | 2001-12-31 | Abbott Lab | A controlled release formulation for poorly soluble basic drugs |
-
2002
- 2002-10-08 SI SI200200242A patent/SI21300A/sl not_active IP Right Cessation
-
2003
- 2003-06-10 UA UAA200504316A patent/UA80990C2/uk unknown
- 2003-10-06 RS YU20050276A patent/RS52818B/sr unknown
- 2003-10-06 AU AU2003273212A patent/AU2003273212A1/en not_active Abandoned
- 2003-10-06 WO PCT/SI2003/000034 patent/WO2004032904A1/fr not_active Application Discontinuation
- 2003-10-06 EA EA200500613A patent/EA007488B1/ru not_active IP Right Cessation
- 2003-10-06 SI SI200332359T patent/SI1560568T1/sl unknown
- 2003-10-06 EP EP03755718.8A patent/EP1560568B1/fr not_active Expired - Lifetime
- 2003-10-06 PL PL374487A patent/PL208591B1/pl unknown
-
2005
- 2005-04-06 HR HRP20050312AA patent/HRP20050312B1/hr not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL374487A1 (en) | 2005-10-31 |
EP1560568B1 (fr) | 2014-03-26 |
HRP20050312B1 (hr) | 2014-09-26 |
HRP20050312A2 (en) | 2006-02-28 |
UA80990C2 (en) | 2007-11-26 |
RS20050276A (en) | 2007-06-04 |
EA007488B1 (ru) | 2006-10-27 |
AU2003273212A1 (en) | 2004-05-04 |
PL208591B1 (pl) | 2011-05-31 |
WO2004032904A1 (fr) | 2004-04-22 |
EA200500613A1 (ru) | 2005-10-27 |
SI1560568T1 (sl) | 2014-08-29 |
EP1560568A1 (fr) | 2005-08-10 |
SI21300A (sl) | 2004-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS51756B (sr) | Čvrste farmaceutske formulacije koje sadrže telmisartan | |
AU2003274681A1 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
HRP20040996B1 (en) | High drug load tablet | |
ATE302616T1 (de) | Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe | |
HRP20010463B1 (en) | Controlled release galantamine composition | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
EA200600598A1 (ru) | Лекарственные формы замедленного высвобождения | |
TW200505406A (en) | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base | |
DE69942154D1 (de) | Medikamenthaltige zusammensetzung in aerosolform | |
BR0003158A (pt) | Formulação de dosagem oral de derretimentoinstantâneo | |
DE69940557D1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
HUP0401911A2 (hu) | Kártevőirtó készítmények és alkalmazásuk | |
CY1107819T1 (el) | Φαρμακευτικη διαμορφωση της ολανζαπινης | |
ME00706B (fr) | Composition pharmaceutique comprenant une entacapone ou nitecapone, de meme qu'un derive de cellulose reticule | |
RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
MXPA03008420A (es) | Forma farmaceutica solida oralmente dispersa. | |
ES2130081B1 (es) | Comprimido de maleato de trimebutina con recubrimiento laminar. | |
WO2005065639A3 (fr) | Nouvelles compositions pharmaceutiques | |
RS52818B (sr) | Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat | |
ATE412404T1 (de) | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon | |
DK1546067T3 (da) | Rygesammensætning | |
BR0001144B1 (pt) | Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase | |
WO2005037247A3 (fr) | Formulations matricielles de doxazosine a administration orale | |
HRPK20040924B3 (en) | Preparation based on curcumae longae rhizomae roots | |
RU2003114406A (ru) | Витаминная композиция |